{"id":"W2165575701","doi":"10.1016/j.cell.2012.02.053","title":"Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Cell","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":744,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research","keywords":"Kinome; Triple-negative breast cancer; MEK inhibitor; Biology; Cancer research; MAPK/ERK pathway; Reprogramming; Receptor tyrosine kinase; Kinase; Trametinib; Gene knockdown; Cancer; Cell biology; Breast cancer; Apoptosis; Biochemistry; Cell; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}